| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCR-033 | Gamabufalin | >98%,Standard References |
|
| DCN-019 | Neoline，Bullatine B | >98%,Standard References |
|
| DCZ-028 | Hyodeoxycholic acid | >98%,Standard References |
|
| DCQ-013 | Deoxycholic acid | >98%,Standard References |
|
| DCX-027 | Ursodeoxycholic acid | >98%,Standard References |
|
| DCD-045 | Cholic acid | >98%,Standard References |
|
| DCN-016 | Nystose | >98%,Standard References |
|
| DCC-074 | Hydnocarpin | >98%,Standard References |
|
| DCS-024 | Silibinin | >98%,Standard References |
|
| DCS-072 | Morusin | >98%,Standard References |
|
| DCY-055 | polygalaxanthone III | >98%,Standard References |
|
| DCX-032 | neomangiferin | >98%,Standard References |
|
| DCL-041 | Picroside III | >98%,Standard References |
|
| DCW-003 | Vindoline | >98%,Standard References |
|
| DCC-061 | Chasmanine | >98%,Standard References |
|
| DCY-123 | delsoline | >98%,Standard References |
|
| DCW-015 | Aconine | >98%,Standard References |
|
| DCD-070 | Salvianolicacid C | >98%,Standard References |
|
| DCQ-077 | Apiin | >98%,Standard References |
|
| DCX-029 | Schaftoside | >98%,Standard References |
|
| DCY-153 | Isoschaftoside | >98%,Standard References |
|
| DCQ-093 | Isoliquiritin apioside | >98%,Standard References |
|
| DCH-023 | obacunone | >98%,Standard References |
|
| DCN-006 | Limonin | >98%,Standard References |
|
| DCS-032 | mulberroside A | >98%,Standard References |
|
| DCC-058 | Bufotaline | >98%,Standard References |
|
| DCN-018 | Taurochenodeoxycholic Acid | >98%,Standard References |
|
| DCN-014 | Tauroursodeoxycholic acid Featured | Tauroursodeoxycholate (Tauroursodeoxycholic acid) is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK. |
|
| DCZ-008 | lithospermic acid | >98%,Standard References |
|
| DCB-063 | baohuoside I | >98%,Standard References |
|
